This plasmid was used as a template for site-directed mutagenesis to create vectors that expressed Ub proteins with each possible single Lys to Arg mutation as well as a Ub protein with all seven Lys residues mutated to Arg.
The fourth one is KnEA, proposed by Zhang et al. [52], and its genetic operators are simulated binary crossover and polynomial mutation as well.
Personalized medicine is becoming a reality for patients with EGFR mutation as well as for the recruitment of patients in certain clinical trials (EML4-ALK translocation, KRAS mutation…).
In this study, residues forming hydrophobic interactions with the substitution groups on the aporphine scaffold of -crebanine (1) were selected for mutation as well and they are Thr1393.37, Gly2185.42, Ala2225.46, and Leu209ECL2.
The mutants that performed the best in the models were again sequence 12 (carrying solely the K101E and K103N mutation) as well as sequence 3, (carrying solely the Y181C mutation).
The effects of the genetic operators, such as the type of crossover and mutation, as well as algorithm parameters, such as population size and range of search space, on the convergence of design-solution were studied.
If an allele is lost by mutation much more often than it is gained by mutation, then mutation, as well as drift, may influence the time to loss.
A third cluster of 13 samples also included 4 tumors with an activated SHH signaling, one of them with a PTCH1 mutation as well.
A polyadenylation signal (AATAAA) can be created at position 94 of forward strand of PRAT consensus sequence by single point mutation, as well as at position 50 of the reverse strand by two mutations.
HLA loci have evolved through mutation as well as recombination [54]; thus HLA alleles cannot be defined by a single nucleotide polymorphism (SNP) but rather by an array of cis-linked SNPs.
Even though, excluding patient Epi203 (harboring TP53 and175His Arg95Ter5Ter CHEK2 mutation) as well as other patients harboring TP53 L2/L3 mutations (n = 129), CHEK2 mutations (n = 4 in total) predicted for resistance to doxorubicin and epirubicin therapy (p = 0.030).
